Literature DB >> 11916537

Multiplicity of mechanisms of serotonin receptor signal transduction.

J R Raymond1, Y V Mukhin, A Gelasco, J Turner, G Collinsworth, T W Gettys, J S Grewal, M N Garnovskaya.   

Abstract

The serotonin (5-hydroxytryptamine, 5-HT) receptors have been divided into 7 subfamilies by convention, 6 of which include 13 different genes for G-protein-coupled receptors. Those subfamilies have been characterized by overlapping pharmacological properties, amino acid sequences, gene organization, and second messenger coupling pathways. Post-genomic modifications, such as alternative mRNA splicing or mRNA editing, creates at least 20 more G-protein-coupled 5-HT receptors, such that there are at least 30 distinct 5-HT receptors that signal through G-proteins. This review will focus on what is known about the signaling linkages of the G-protein-linked 5-HT receptors, and will highlight some fascinating new insights into 5-HT receptor signaling.

Mesh:

Substances:

Year:  2001        PMID: 11916537     DOI: 10.1016/s0163-7258(01)00169-3

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  130 in total

1.  The sleep-wake cycle and motor activity, but not temperature, are disrupted over the light-dark cycle in mice genetically depleted of serotonin.

Authors:  Julia Z Solarewicz; Mariana Angoa-Perez; Donald M Kuhn; Jason H Mateika
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-11-12       Impact factor: 3.619

2.  RGS inhibition at G(alpha)i2 selectively potentiates 5-HT1A-mediated antidepressant effects.

Authors:  Jeffery N Talbot; Emily M Jutkiewicz; Steven M Graves; Crystal F Clemans; Melanie R Nicol; Richard M Mortensen; Xinyan Huang; Richard R Neubig; John R Traynor
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-02       Impact factor: 11.205

3.  Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.

Authors:  José L Moreno; Terrell Holloway; Laura Albizu; Stuart C Sealfon; Javier González-Maeso
Journal:  Neurosci Lett       Date:  2011-01-27       Impact factor: 3.046

Review 4.  CNS involvement in overactive bladder: pathophysiology and opportunities for pharmacological intervention.

Authors:  Karl-Erik Andersson; Rikard Pehrson
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 5.  Monoamine oxidases in development.

Authors:  Chi Chiu Wang; Ellen Billett; Astrid Borchert; Hartmut Kuhn; Christoph Ufer
Journal:  Cell Mol Life Sci       Date:  2012-07-11       Impact factor: 9.261

6.  Antagonist interaction with the human 5-HT(7) receptor mediates the rapid and potent inhibition of non-G-protein-stimulated adenylate cyclase activity: a novel GPCR effect.

Authors:  M T Klein; M Teitler
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

7.  Substitution of 5-HT1A receptor signaling by a light-activated G protein-coupled receptor.

Authors:  Eugene Oh; Takashi Maejima; Chen Liu; Evan Deneris; Stefan Herlitze
Journal:  J Biol Chem       Date:  2010-07-19       Impact factor: 5.157

Review 8.  The serotonin1A receptor: a representative member of the serotonin receptor family.

Authors:  Thomas J Pucadyil; Shanti Kalipatnapu; Amitabha Chattopadhyay
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

9.  A 3-synapse positive feedback loop regulates the excitability of an interneuron critical for sensitization in the leech.

Authors:  Kevin M Crisp; Kenneth J Muller
Journal:  J Neurosci       Date:  2006-03-29       Impact factor: 6.167

10.  Pharmacological analysis of the novel, rapid, and potent inactivation of the human 5-Hydroxytryptamine7 receptor by risperidone, 9-OH-Risperidone, and other inactivating antagonists.

Authors:  Jessica A Knight; Carol Smith; Nicole Toohey; Michael T Klein; Milt Teitler
Journal:  Mol Pharmacol       Date:  2008-11-07       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.